Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
Top Cited Papers
Open Access
- 23 April 2020
- journal article
- letter
- Published by Elsevier BV in Journal of Infection
- Vol. 81 (2), 318-356
- https://doi.org/10.1016/j.jinf.2020.04.017
Abstract
No abstract availableFunding Information
- Ministero della Salute
This publication has 10 references indexed in Scilit:
- A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19The New England Journal of Medicine, 2020
- Chloroquine and hydroxychloroquine in covid-19BMJ, 2020
- Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoVJournal of Infection, 2020
- The Accumulation and Metabolism Characteristics of Rare Earth Elements in Sprague–Dawley RatsInternational Journal of Environmental Research and Public Health, 2020
- Baricitinib as potential treatment for 2019-nCoV acute respiratory diseaseThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritisRheumatology, 2019
- Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from diseaseRespirology, 2018
- Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosisThe Journal of cell biology, 2002
- Validation of a modified Early Warning Score in medical admissionsQJM: An International Journal of Medicine, 2001